Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapyGloria B. Kim(Parker Institute for Cancer Immunotherapy), James L. Riley(Parker Institute for Cancer Immunotherapy)Science Translational MedicineAugust 31, 202210.1126/scitranslmed.abo6135Cited by 38SaveCiteExport RISWatch citationsRelated PapersDifferential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments|Cell Reports|2018|62